Bumper Hemp Crops Promise Profit for Farmers and Cannabis Companies

New York NY – November 1, 2018 – This year will see the largest U.S. hemp crop since changes to federal law created an avenue for production to start again, turning over decades of fallowed industry.   Thousands of acres of hemp will be harvested across 19 states. Kentucky is seeing particularly good crops, due […]

Sugarmade Executes on $40 Million Definitive Agreement to Acquire Sky Unlimited, LLC Creating Hydroponic Supply Powerhouse

MONROVIA, California, November 1, 2018 – Sugarmade, Inc. (OTCQB:SGMD) today announces the signing of a binding Definitive Agreement to acquire Sky Unlimited, LLC, which through its AthenaUnited.com operations and website offers multiple popular hydroponic brands to several growing agricultural cultivation sectors. As a result of this acquisition, Sugarmade is raising its revenue guidance for calendar […]

Emerging Business Opportunities Dramatically Increase as Canadian Cannabis Market Swells

Palm Beach, FL – (November 1, 2018) – The Canadian Cannabis industry is unsurprisingly on fire as it rides the wave provided by full-recreational legalization. Consumers have already dumped millions into the burgeoning marijuana economy to the north of the US border, and the growth is only forecasted to continue. According to a Brookings Institute […]

PotNetwork Holdings, Inc. Prepares To List on Canadian Securities Exchange (“CSE”)

Company to Seek Dual Listing to Take Advantage of Rapidly Growing Canadian Cannabis Market Sector   FORT LAUDERDALE, Fla.– (November 1, 2018) — PotNetwork Holdings, Inc. (OTCPK:POTN) (the “Company”) announced today that it is preparing to list its common stock on the Canadian Securities Exchange (“CSE”) operated by CNSX Markets Inc.  The Company has engaged […]

Moleculin Announces Significant Milestone Achieved in Glioblastoma Trial

WP1066 demonstrating drug bioavailability in on-going Phase 1 clinical trial   HOUSTON – November 1, 2018 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf […]